Cumberland Pharmaceuticals Provides Hospital In-Service Webcast for Ac... ( NASHVILLE Tenn. May 18 /- Cumberland ...)

Cumberland Pharmaceuticals Provides Hospital In-Service Webcast for Acetadote(R)

Date:5/18/2009

NASHVILLE, Tenn., May 18 /PRNewswire/ -- Cumberland Pharmaceuticals announced today the launch of an online in-service program for hospitals using Acetadote (acetylcysteine) Injection, the company's intravenous treatment for acetaminophen overdose.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090518/CL18638 )

Available at www.acetadote.net, the webcast provides hospital pharmacists and physicians, educators and other healthcare providers with information and guidelines on dosage and administration of Acetadote for treatment of acetaminophen poisoning. The webcast is designed to supplement and reinforce information provided by Cumberland's hospital sales force through convenient, anytime access to training. This online program will also provide detailed training to hospitals where personal in-service visits by a Cumberland representative are not readily available.

"We are pleased to offer this additional level of support for healthcare providers using our product," said A.J. Kazimi, CEO of Cumberland Pharmaceuticals. "Acetadote is a potentially life-saving drug, and as use of the product continues to rise we believe it is important to provide healthcare professionals with as much information as possible to facilitate proper administration."

About Acetadote

Acetadote is used in the emergency department and hospital inpatient setting to prevent or lessen potential liver damage resulting from an overdose of acetaminophen, a common ingredient in many over-the-counter and prescription medications. It is the only approved injectable product in the United States for the treatment of acetaminophen overdose, the leading cause of toxic drug ing
'/>"/>

0

GOOD

Page: 1 2 3
Related biology technology :

1. Cumberland Pharmaceuticals Taps Industry Veteran for Key Executive Position
2. Neurotech Announces the Opening of Its GMP Manufacturing Facility in Cumberland, Rhode Island
3. Cumberland Pharmaceuticals Appoints Lee Product Director
4. Cumberland Emerging Technologies and UT Research Foundation Sign License Agreement for New Technology
5. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
11. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer

Post Your Comments:

Cumberland Pharmaceuticals Provides Hospital In-Service Webcast for Ac...( NASHVILLE Tenn. May 18 /- Cumberland ...)